title: 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes.
authors.affiliation: Department of Internal Medicine A, Poria Medical Center, Lower Galilee 15208, Israel. navablum@hotmail.com
authors.forename: Arnon
authors.initials: A
authors.lastname: Blum
authors.forename: Claudia
authors.initials: C
authors.lastname: Simsolo
authors.forename: Yonathan
authors.initials: Y
authors.lastname: Hasin
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001161:Arteriosclerosis / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control; D023903:Coronary Restenosis / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D017202:Myocardial Ischemia / Q000517:prevention & control
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids